Deutsche Bank initiated coverage of Albertsons with a rating of Hold
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/15/2026 | $14.00 | Equal-Weight → Underweight | Morgan Stanley |
| 1/8/2026 | Hold | Deutsche Bank | |
| 8/20/2025 | $27.00 | Overweight | Analyst |
| 7/22/2025 | $27.00 | Neutral → Buy | UBS |
| 7/21/2025 | $19.00 | Underweight | Barclays |
| 5/7/2025 | $25.00 | Market Perform → Outperform | BMO Capital Markets |
| 4/16/2025 | $26.00 → $24.00 | Outperform | Telsey Advisory Group |
| 2/4/2025 | $26.00 | Buy | Goldman |
Morgan Stanley downgraded Albertsons from Equal-Weight to Underweight and set a new price target of $14.00
Deutsche Bank initiated coverage of Albertsons with a rating of Hold
Analyst resumed coverage of Albertsons with a rating of Overweight and set a new price target of $27.00
4/A - Albertsons Companies, Inc. (0001646972) (Issuer)
4 - Albertsons Companies, Inc. (0001646972) (Issuer)
4/A - Albertsons Companies, Inc. (0001646972) (Issuer)
Announces 13% Increase in Common Stock Dividend Increases Remaining Share Repurchase Authorization to $2 billion Provides Fiscal 2026 Outlook Albertsons® Companies, Inc. (NYSE:ACI) (the "Company") today reported results for the fourth quarter of fiscal 2025 and full year fiscal 2025, which ended Feb. 28, 2026 and included 13 and 53 weeks, respectively. Fourth Quarter of Fiscal 2025 Highlights Identical sales increased 0.7% Digital sales increased 16% Loyalty members increased 12% to 51.2 million Net loss of $(481) million, or $(0.94) per share, inclusive of the $600 million charge, net of tax, or $(1.18) per share, related to the Opioid Settlement Framework (as defined herei
Albertsons® Companies, Inc. (NYSE:ACI) today announced it has reached a $774 million settlement framework to resolve substantially all of the opioid-related claims brought against the Company by state, local and tribal government entities nationally, if all conditions are satisfied. This settlement framework marks a significant step toward resolving opioid-related litigation, and Albertsons Cos. believes the settlement framework is in the best interest of all parties. This settlement is not an admission of wrongdoing or liability. For years, Albertsons Cos. has invested in strong pharmacy practices designed to promote the safe and appropriate use of prescription medications. The Company
Albertsons® Companies, Inc. (NYSE:ACI) (the "Company") today announced its Board of Directors has declared an increased cash dividend for the first quarter of fiscal 2026 of $0.17 per share of common stock, representing a new annualized dividend of $0.68 per share. The quarterly cash dividend is payable on May 8, 2026, to stockholders of record as of the close of business on April 24, 2026. This increase reflects the Company's confidence in its core business, the strength of the underlying free cash flow generation and its balanced approach to capital allocation over time. Since the Company's initial public offering in June 2020, the Company's dividend has grown from an annualized level o
8-K - Albertsons Companies, Inc. (0001646972) (Filer)
SCHEDULE 13G/A - Albertsons Companies, Inc. (0001646972) (Subject)
8-K - Albertsons Companies, Inc. (0001646972) (Filer)
Announces 13% Increase in Common Stock Dividend Increases Remaining Share Repurchase Authorization to $2 billion Provides Fiscal 2026 Outlook Albertsons® Companies, Inc. (NYSE:ACI) (the "Company") today reported results for the fourth quarter of fiscal 2025 and full year fiscal 2025, which ended Feb. 28, 2026 and included 13 and 53 weeks, respectively. Fourth Quarter of Fiscal 2025 Highlights Identical sales increased 0.7% Digital sales increased 16% Loyalty members increased 12% to 51.2 million Net loss of $(481) million, or $(0.94) per share, inclusive of the $600 million charge, net of tax, or $(1.18) per share, related to the Opioid Settlement Framework (as defined herei
Albertsons® Companies, Inc. (NYSE:ACI) will release financial results for the fourth quarter and fiscal 2025, which ended Feb. 28, 2026, before the market opens on Tuesday, April 14, 2026. Albertsons Cos. will host a conference call that day at 8:30 a.m. (EDT). The conference call will be available at the following address by accessing the "Events & Presentations" link included therein: http://albertsonscompanies.com/investors A replay of the conference call will be available for approximately two weeks following completion of the call. About Albertsons Companies Albertsons Companies is a leading food and drug retailer in the United States. As of Nov. 29, 2025, the Company operated
Albertsons® Companies, Inc. (NYSE:ACI) (the "Company") today reported results for the third quarter of fiscal 2025, which ended November 29, 2025. Third Quarter of Fiscal 2025 Highlights Identical sales increased 2.4% Digital sales increased 21% Loyalty members increased 12% to 49.8 million Net income of $293 million, or $0.55 per share Adjusted net income of $390 million, or $0.72 per share Adjusted EBITDA of $1,039 million "In the third quarter, we delivered solid results and continued to advance our strategic priorities," said Susan Morris, Chief Executive Officer. "Our investments in technology and AI are fundamentally reshaping how we operate and serve our custom
SC 13G/A - Albertsons Companies, Inc. (0001646972) (Subject)
SC 13G - Albertsons Companies, Inc. (0001646972) (Subject)
SC 13G/A - Albertsons Companies, Inc. (0001646972) (Subject)
Seasoned Global Technology Leader Brings Deep Digital, Data and AI Expertise Albertsons® Companies, Inc. (NYSE:ACI) ("the Company") today announced the appointment of Brian Rice to its Board of Directors, effective Feb. 25, 2026. The Company's board has now expanded to 11 members. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260227107536/en/Albertsons Companies Appoints Brian Rice to Board of Directors. Mr. Rice is a seasoned global technology executive with more than 30 years of experience leading large-scale digital transformation, technology modernization, and operational excellence across some of the world's most recogni
Pinkham previously served as Chief Human Resources Officer at Galderma and Chief People Officer at Heineken USA Albertsons Companies, Inc. (NYSE:ACI) today announced that Allison Pinkham will join the Company as Executive Vice President and Chief Human Resources Officer effective Feb. 16, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260126966952/en/Albertsons Companies Names Allison Pinkham Executive Vice President and Chief Human Resources Officer. Allison brings over 25 years of executive leadership and human resources experience to Albertsons Cos. Allison was most recently the Chief Human Resources Officer and Execu
Jim Donald Retires from the Board; Kim Fennebresque Appointed as Chair David Zinsner, EVP and CFO of Intel, Appointed as Independent Director Albertsons® Companies, Inc. (NYSE:ACI) ("the Company") today announced that Jim Donald, Chair of the Board, has elected to retire from his role and from the Board. Kim Fennebresque has been elected as the new Chair and David Zinsner, Executive Vice President and Chief Financial Officer of Intel Corporation, will join the Board as an independent director. Allen Gibson has also retired from the Board. Mr. Fennebresque has served as an independent director since 2015, providing leadership and insights on financial strategy, strategic initiatives an